Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-01-05 @ 6:07 PM
Study NCT ID:
NCT01435395
Status:
COMPLETED
Last Update Posted:
2016-04-27
First Post:
2011-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2016-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-14
First Submit QC Date:
None
Study First Post Date:
2011-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-25
Last Update Post Date:
2016-04-27
Last Update Post Date Type:
ESTIMATED